HIMS

34.10

0.61% -0.21

Handel nachbörslich: 33.94 -0.16 -0.47%

Hims Hers Health Inc (HIMS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HIMS? Forum Prognose

Schlusskurs vom Vortag:

$34.31

Offen:

$34.06

24-Stunden-Volumen:

9.13M

Relative Volume:

0.40

Marktkapitalisierung:

$7.76B

Einnahmen:

$1.78B

Nettoeinkommen (Verlust:

$164.40M

KGV:

49.42

EPS:

0.69

Netto-Cashflow:

$236.51M

1W Leistung:

-2.71%

1M Leistung:

-14.24%

6M Leistung:

-30.99%

1J Leistung:

+28.39%

1-Tages-Spanne:

$33.80

$34.75

1-Wochen-Bereich:

$33.50

$35.14

52-Wochen-Spanne:

$23.97

$72.98

Hims Hers Health Inc Stock (HIMS) Company Profile

Firmenname

Hims Hers Health Inc

Sektor

Healthcare (1131)

Branche

Drug Manufacturers - Specialty & Generic (85)

Telefon

415-851-0195

Adresse

2269 CHESTNUT ST, SAN FRANCISCO

Mitarbeiter

1,637

Twitter

Nächster Verdiensttermin

2025-02-24

Neueste SEC-Einreichungen

HIMS's Discussions on Twitter

Vergleichen Sie HIMS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HIMS Hims Hers Health Inc	34.10	7.81B	1.78B	164.40M	236.51M	0.69
ZTS Zoetis Inc	125.98	55.63B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	15.76	49.44B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.09	45.11B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	31.56	36.59B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	502.90	21.84B	3.08B	1.24B	1.07B	25.61

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Overweight
2025-10-21	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2025-06-23	Herabstufung	Needham	Buy → Hold
2025-06-04	Bestätigt	Needham	Buy
2025-04-29	Herabstufung	TD Cowen	Buy → Hold
2025-02-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-01-10	Herabstufung	Citigroup	Neutral → Sell
2025-01-07	Eingeleitet	BTIG Research	Buy
2024-12-17	Eingeleitet	Morgan Stanley	Overweight
2024-11-14	Herabstufung	BofA Securities	Buy → Underperform
2024-08-22	Eingeleitet	Needham	Buy
2024-08-09	Herabstufung	Imperial Capital	Outperform → In-line
2024-05-22	Herabstufung	Citigroup	Buy → Neutral
2024-04-16	Herabstufung	Jefferies	Buy → Hold
2024-04-10	Eingeleitet	Canaccord Genuity	Buy
2024-02-28	Hochstufung	Imperial Capital	In-line → Outperform
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2023-12-07	Eingeleitet	Imperial Capital	In-line
2023-07-28	Eingeleitet	TD Cowen	Outperform
2023-04-11	Eingeleitet	Robert W. Baird	Neutral
2023-02-09	Hochstufung	Jefferies	Hold → Buy
2022-11-08	Hochstufung	BofA Securities	Neutral → Buy
2022-11-08	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2022-10-17	Herabstufung	Piper Sandler	Overweight → Neutral
2022-09-07	Eingeleitet	Truist	Hold
2022-07-15	Eingeleitet	SVB Leerink	Underperform
2022-04-14	Eingeleitet	Guggenheim	Buy
2022-04-01	Fortgesetzt	Credit Suisse	Outperform
2022-03-10	Eingeleitet	Deutsche Bank	Hold
2021-12-02	Eingeleitet	Jefferies	Hold
2021-11-11	Hochstufung	Piper Sandler	Neutral → Overweight
2021-07-06	Eingeleitet	BofA Securities	Neutral
2021-05-20	Hochstufung	Credit Suisse	Neutral → Outperform
2021-04-21	Eingeleitet	Truist	Hold
2021-03-09	Eingeleitet	Credit Suisse	Neutral
2021-03-02	Hochstufung	Citigroup	Neutral → Buy
2021-02-17	Eingeleitet	Citigroup	Neutral
2021-02-12	Eingeleitet	Piper Sandler	Neutral
2021-02-08	Eingeleitet	Tigress Financial	Buy

Alle ansehen

Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten

02:09 AM

Best Healthcare Stocks Worth WatchingDecember 29th - MarketBeat

02:09 AM

12:35 PM

Hims & Hers Health Stock (HIMS) Opinions on Canadian Market Expansion - Quiver Quantitative

12:35 PM

10:30 AM

Top 10 Most Shorted Stocks: Lucid, MARA, Hims and More - Benzinga

10:30 AM

10:01 AM

TEM vs. HIMS: Which Medical Info Systems Stock Offers Greater Upside - Finviz

10:01 AM

02:26 AM

Hims & Hers stock slides into year-end as investors weigh Ohio buildout and macro calendar - ts2.tech

02:26 AM

Dec 28, 2025

Returns Recap: Why hedge funds are buying Hims Hers Health Inc stockBuy Signal & Expert Approved Momentum Ideas - moha.gov.vn

Dec 28, 2025

Dec 27, 2025

Hims & Hers: A Growth Story Battling Market Skepticism - AD HOC NEWS

Dec 27, 2025

Carnegie Investment Counsel Acquires 61,560 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat

Dec 27, 2025

Dec 26, 2025

Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Dec 26, 2025

Dec 24, 2025

Assessing Hims and Hers After Its 462% Multi Year Surge and Premium Valuation Multiple - Yahoo Finance

Dec 24, 2025

HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? - Finviz

Dec 24, 2025

The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health - The Globe and Mail

Dec 24, 2025

Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking - Stocktwits

Dec 24, 2025

Hims & Hers Health Stock (HIMS) Opinions on Recent Volatility and Expansion - Quiver Quantitative

Dec 24, 2025

Voya Investment Management LLC Buys 52,370 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat

Dec 24, 2025

Hims & Hers quietly scooped up nearly 300,000 square feet in East Valley - The Business Journals

Dec 24, 2025

New Albany gains $200M health care expansion, 400 new jobs - Yahoo

Dec 24, 2025

Dec 23, 2025

Oluyemi Okupe Sells 23,090 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat

Dec 23, 2025

3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run - The Globe and Mail

Dec 23, 2025

Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows - The Globe and Mail

Dec 23, 2025